Compare MFM & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MFM | SWKH |
|---|---|---|
| Founded | 1986 | 1996 |
| Country | United States | United States |
| Employees | N/A | 9 |
| Industry | Finance Companies | Diversified Financial Services |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.1M | 198.4M |
| IPO Year | N/A | N/A |
| Metric | MFM | SWKH |
|---|---|---|
| Price | $5.24 | $17.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 88.3K | 7.9K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 4.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $52.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $176.33 | ★ $9.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.94 | $13.00 |
| 52 Week High | $5.67 | $18.66 |
| Indicator | MFM | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 29.73 | 51.65 |
| Support Level | $5.25 | $16.65 |
| Resistance Level | $5.47 | $17.08 |
| Average True Range (ATR) | 0.05 | 0.27 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 5.69 | 72.89 |
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but it may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.